Literature DB >> 22095544

Evolution of immunity: no development without risk.

Alexander B Sigalov1.   

Abstract

Signal transduction by cell surface receptors in the context of heterogeneous and variable cellular environments plays a pivotal role in regulating many biological processes, including development, activation, and homeostasis of the immune system. In some receptors, extracellular ligand-binding and intracellular signaling domains are located on the same protein chain (single-chain receptors), while in the so-called multichain immune recognition receptors (MIRRs), recognition and signaling functions are separated between different protein chains. Why did nature separate recognition and signaling functions for MIRRs, thereby increasing the risk of malfunction and potential attack by pathogens? The risk is real: in order to escape the immune response, viruses are able to disrupt functional coupling between recognition and signaling aspects of MIRR machinery. Intrinsic disorder of intracellular signal-generating regions of MIRRs adds further intrigue to the story. Why did nature select protein disorder for MIRRs to translate recognition of distinct antigens into appropriate activation signals that would induce specific functional outcomes? Here, I suggest that nature takes the risks associated with intrareceptor separation of functions as well as with the chaos and indeterminacy of protein disorder in exchange for providing diversity and variability of signal transduction. Not only does this phenomenon serve as the molecular basis for the development and evolution of the immune and other complex biological systems, but it fits closely to Darwinian evolutionary biology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22095544     DOI: 10.1007/s12026-011-8256-4

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  40 in total

Review 1.  What does it mean to be natively unfolded?

Authors:  Vladimir N Uversky
Journal:  Eur J Biochem       Date:  2002-01

Review 2.  Protein-protein interactions as a target for drugs in proteomics.

Authors:  Alexander I Archakov; Vadim M Govorun; Alexander V Dubanov; Yuri D Ivanov; Alexander V Veselovsky; Paul Lewi; Paul Janssen
Journal:  Proteomics       Date:  2003-04       Impact factor: 3.984

Review 3.  Emerging classes of protein-protein interaction inhibitors and new tools for their development.

Authors:  Len Pagliaro; Jakob Felding; Karine Audouze; Søren Jensby Nielsen; Robert B Terry; Christian Krog-Jensen; Steven Butcher
Journal:  Curr Opin Chem Biol       Date:  2004-08       Impact factor: 8.822

Review 4.  Small-molecule inhibitors of protein-protein interactions: progressing towards the dream.

Authors:  Michelle R Arkin; James A Wells
Journal:  Nat Rev Drug Discov       Date:  2004-04       Impact factor: 84.694

Review 5.  The avian B-cell receptor complex: distinct roles of Igalpha and Igbeta in B-cell development.

Authors:  Kelly A Pike; Ehtesham Baig; Michael J H Ratcliffe
Journal:  Immunol Rev       Date:  2004-02       Impact factor: 12.988

Review 6.  Multichain immune recognition receptor signaling: different players, same game?

Authors:  Alexander B Sigalov
Journal:  Trends Immunol       Date:  2004-11       Impact factor: 16.687

7.  Intrinsically disordered regions of human plasma membrane proteins preferentially occur in the cytoplasmic segment.

Authors:  Yoshiaki Minezaki; Keiichi Homma; Ken Nishikawa
Journal:  J Mol Biol       Date:  2007-02-22       Impact factor: 5.469

8.  Lipid-binding activity of intrinsically unstructured cytoplasmic domains of multichain immune recognition receptor signaling subunits.

Authors:  Alexander B Sigalov; Dikran A Aivazian; Vladimir N Uversky; Lawrence J Stern
Journal:  Biochemistry       Date:  2006-12-19       Impact factor: 3.162

9.  HIV-1 gp41 and TCRalpha trans-membrane domains share a motif exploited by the HIV virus to modulate T-cell proliferation.

Authors:  Tomer Cohen; Shmuel Jaffe Cohen; Niv Antonovsky; Irun R Cohen; Yechiel Shai
Journal:  PLoS Pathog       Date:  2010-09-02       Impact factor: 6.823

10.  Qualitatively differential regulation of T cell activation and apoptosis by T cell receptor zeta chain ITAMs and their tyrosine residues.

Authors:  Wook-Jin Chae; Heung-Kyu Lee; Jin-Hwan Han; Sang-Won Vincent Kim; Alfred L M Bothwell; Tomohiro Morio; Sang-Kyou Lee
Journal:  Int Immunol       Date:  2004-08-09       Impact factor: 4.823

View more
  4 in total

1.  Membrane-mediated regulation of the intrinsically disordered CD3ϵ cytoplasmic tail of the TCR.

Authors:  Cesar A López; Anurag Sethi; Byron Goldstein; Bridget S Wilson; S Gnanakaran
Journal:  Biophys J       Date:  2015-05-19       Impact factor: 4.033

2.  Generation of Potent T-cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric Immunoreceptors.

Authors:  Enxiu Wang; Liang-Chuan Wang; Ching-Yi Tsai; Vijay Bhoj; Zack Gershenson; Edmund Moon; Kheng Newick; Jing Sun; Albert Lo; Timothy Baradet; Michael D Feldman; David Barrett; Ellen Puré; Steven Albelda; Michael C Milone
Journal:  Cancer Immunol Res       Date:  2015-05-04       Impact factor: 11.151

3.  SCHOOL of nature: ligand-independent immunomodulatory peptides.

Authors:  Alexander B Sigalov
Journal:  Drug Discov Today       Date:  2020-05-12       Impact factor: 7.851

Review 4.  Targeting Intramembrane Protein-Protein Interactions: Novel Therapeutic Strategy of Millions Years Old.

Authors:  Alexander B Sigalov
Journal:  Adv Protein Chem Struct Biol       Date:  2017-07-24       Impact factor: 3.507

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.